An updated meta-analysis of TAVR in patients at intermediate risk for SAVR

• Published in: Cardiovascular revascularization medicine Vol. 20; no. 1; pp. 57 - 69
• Main Authors: Lazkani, Mohamad, Singh, Nirmal, Howe, Carol, Patel, Nachiket, Colón, Modesto J., Tasset, Mark, Amabile, Orazio, Morris, Michael, Fang, H. Kenith, Pershad, Ashish
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.01.2019
• Subjects: Aged; Aged, 80 and over; Aortic stenosis; Aortic Valve - diagnostic imaging; Aortic Valve - physiopathology; Aortic Valve - surgery; Aortic Valve Stenosis - diagnostic imaging; Aortic Valve Stenosis - mortality; Aortic Valve Stenosis - physiopathology; Aortic Valve Stenosis - surgery; Female; Humans; Intermediate surgical risk; Male; Postoperative Complications - mortality; Risk Assessment; Risk Factors; SAVR; TAVR; Time Factors; Transcatheter Aortic Valve Replacement - adverse effects; Transcatheter Aortic Valve Replacement - mortality; Treatment Outcome; Aortic stenosis; SAVR; Intermediate surgical risk; TAVR

Transcatheter aortic valve replacement (TAVR) has been approved for use in patients with severe aortic stenosis at intermediate, high and extreme surgical risk. This meta-analysis was performed to assess the safety and efficacy of TAVR compared to surgical aortic valve replacement (SAVR) in intermed...